Long-term outcomes following ultrathin vs thin-strut drug-eluting stents for percutaneous coronary intervention: an updated systematic review and meta-analysis of randomized control trials

Overview

cited authors

Yasmin, Farah; Zaidi, Syeda Farwa; Moeed, Abdul; Khan, Muneeba; Ali, Eman; Asghar, Muhammad Sohaib; Ullah, Waqas; Savage, Michael P.; Vishnevsky, Alec; Ruggiero, Nicholas J.; Fischman, David L.

Publication Date

January 1, 2024

webpage

Web of Science

published in

AMERICAN JOURNAL OF CARDIOVASCULAR DISEASE Journal

Research

keywords

Major adverse cardiovascular events
drug eluting stents
target lesion revascularization

301 E Princeton St., Orlando, FL 32804 | FH.RAS@AdventHealth.com | 407-200-2901

The information on this website is not a substitute for examination, diagnosis, and medical care provided by a licensed and qualified health professional. Please consult your physician before undertaking any form of medical treatment and/or adopting any exercise program or dietary guidelines. If you think you may have a medical emergency, call your physician or 911 immediately. AdventHealth Research Institute reserves the right to add, remove or edit content on this page at its sole discretion.